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Deficient T Cell Fate Specification
in Mice with an Induced Inactivation of Notch1
the achaete-scute family. Notch activation results in re-
pression of achaete-scute genes in a subset of precur-
sor cells that consequently give rise to neuroepidermal
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Joost van Meerwijk,²‖ H. Robson MacDonald,²
and Michel Aguet*§ cells. Accordingly, overexpression of Notch leads to an
increase of neuroepidermal cells at the expense of neu-*Swiss Institute for Experimental Cancer Research
1066 Epalinges roblasts, whereas lack of functional Notch protein leads
to continued expression of the achaete-scute genes andSwitzerland
²Ludwig Institute for Cancer Research thereby to an excess of neuroblasts (reviewed in Green-
wald and Rubin, 1992; Ghysen and Dambly-Chaudiere,Lausanne Branch
University of Lausanne 1993; Artavanis-Tsakonas et al., 1995; Simpson, 1995).
Notch receptors are large conserved transmembrane1066 Epalinges
Switzerland proteins with ectodomains that contain up to 36 EGF-
like repeats involved in ligand interaction (Rebay et al.,³Genentech, Incorporated
1 DNA Way 1991) and three copies of a cysteine-rich Lin-12/Notch
(LN) motif of unknown function. Their cytoplasmic do-South San Francisco, California 94080
mains contain six ankyrin repeats that constitute a puta-
tive protein±protein interaction site and a C-terminal
PEST sequence. Notch ligands are also membrane an-
Summary chored and belong to the Serrate- or Delta-like gene
family (Fehon et al., 1990; Fleming et al., 1990; Betten-
Notch proteins are cell surface receptors that mediate hausen et al., 1995; Chitnis et al., 1995; Lindsell et al.,
developmental cell specification events. To explore 1995; Nye and Kopan, 1995; Shawber et al., 1996).
the function of murine Notch1, an essential portion of To date, four mammalian Notch homologs (Notch1-4)
the gene was flanked with loxP sites and inactivation have been identified (Weinmaster et al., 1991, 1992;
induced via interferon-regulated Cre recombinase. Reaume et al., 1992; del Amo et al., 1993; Lardelli and
Mice with a neonatally induced loss of Notch1 function Lendahl, 1993; Lardelli et al., 1994; Uyttendaele et al.,
were transiently growth retarded and had a severe 1996). Vertebrate Notch genes are expressed in environ-
deficiency in thymocyte development. Competitive re- ments where cell fate changes take place. In addition to
population of lethally irradiated wild-type hosts with neuroepithelial tissue, Notch gene expression is found in
wild-type- and Notch1-deficient bone marrow revealed the epidermis, in particular in hair follicles (Kopan and
a cell autonomous blockage in T cell development at Weintraub, 1993), in dental epithelium (Mitsiadis et al.,
an early stage, before expression of T cell lineage 1997), in the intestinal epithelium (Weinmaster et al.,
markers. Notch1-deficient bone marrow did, however, 1992), in hematopoietic precursors (Milner et al., 1994),
contribute normally to all other hematopoietic lin- and also in the thymus (Hasserjian et al., 1996).
eages. These findings suggest that Notch1 plays an The role of Notch family members in mammalian cell
obligatory and selective role in T cell lineage induction. fate specification was explored both through gene over-
expression and gene inactivation. The discovery of a
chromosomal translocation in some human T lympho-
Introduction blastic leukemias that resulted in a deletion of the ecto-
domain of the human Notch1 gene, then designated
Maintenance of pluripotency, cell fate specification, and TAN-1 (Ellisen et al., 1991), suggested that Notch1 might
differentiation are processes that govern both embry- thereby become constitutively activated. This observa-
onic development and homeostasis of self-renewing tis- tion stimulated a number of gain of function experiments
sues throughout adulthood. Among the pathways that in which a cytoplasmic domain of a Notch protein was
mediate such events, the Notch pathway has been ex- expressed to activate the pathway. Thus, overexpres-
tensively characterized in a number of developmental sion of the intracellular domain of mouse Notch1 re-
systems and shown to regulate cell fate specification sulted in repression of myogenesis in cultured cells (Ko-
(Artavanis-Tsakonas et al., 1995). This paradigm emerged pan et al., 1994). Similarly, activated Notch1 prevented
notably from studies on embryonic neurogenesis in pluripotent embryonic carcinoma cells from differentiat-
Drosophila melanogaster. The Drosophila nervous sys- ing into neurons but not into glia cells (Nye et al., 1994)
tem is derived from equipotent precursor cells that can and myeloid progenitor cells from differentiating into
adopt two distinct cell fates to become either neuro- granulocytes (Milner et al., 1996). Cocultivation of fibro-
blasts or neuroepidermal cells. Precursor cells express blastoid cells that expressed the Notch1 ligand Jagged
a set of basic helix-loop-helix transcription factors of with myoblasts that expressed Notch1 resulted in inhibi-
tion of myoblast differentiation (Lindsell et al., 1995).
Altogether, these experiments did not allow it to distin-§ To whom correspondence should be addressed (e-mail: michel.
guish between an instructive versus a permissive roleaguet@isrec.unil.ch).
of Notch signaling. That Notch1 is involved in mamma-‖ Present address: I. N. S. E. R. M., CHU-Papan, Toulouse CEDEX
31024, France. lian cell fate determination was suggested by constitu-
Immunity
548
Figure 1. Inducible Targeting of the Notch1
Gene
(A) Schematic representation of the murine
Notch1 protein. The protein contains 2531
amino acid residues that encompass a signal
peptide, 36 EGF repeats (EGF), a cystein-rich
region (LN), a transmembrane domain (TM),
cytoplasmic ankyrin repeats (Cdc10), and a
PEST sequence. The genomic organization
of the Notch1 gene was determined only in
part (1); black boxes, exons coding for the
leader peptide and the first EGF repeat. Ho-
mologous recombination of the targeting
vector introduced three loxP sites (filled trian-
gles) plus a neomycin phosphotransferase
gene (PGK-neo) into the Notch1 locus (2),
thereby flanking the exon coding for the
leader peptide with two loxP sites. Transient
transfection of Cre-recombinase into tar-
geted ES cells resulted in three possible re-
combination events, two of which are illus-
trated: loss of the PGK-neo cassette only
resulted in a Notch1 locus in which a 3.7 kb
gene segment harboring the exon coding for
the signal peptide was flanked by two loxP
sites (3); loss of the loxP-flanked segment
containing the PGK-neo cassette plus the 3.5
kb Notch1 gene portion resulted in the dele-
tion of part of the putative Notch1 promoter
plus the exon encoding the signal peptide (4).
Arrows indicate EcoRI fragments that differ
in size between the wild-type locus (Wt) (1),
the locus after homologous insertion of the
targeting vector (2), and the locus after delet-
ing the loxP-flanked 3.5 kb gene segment (4).
RI, EcoRI; B, BamHI.
(B) Southern blot analysis of EcoRI-digested
genomic ES-cell DNA. The probe indicated in
(A) revealed a 5.8 kb fragment from the wild-
type allele (lane 1). After homologous inser-
tion of the replacement vector, the targeted
allele gave rise to a 3.7 kb band (lane 2). Tran-
sient transfection of Cre-recombinase into
the targeted ES cells resulting in the loss of
the PGK-neo cassette only converted the 3.7
kb fragment into a 5.8 kb fragment (lane 3).
The loss of the floxed 3.5 kb gene segment
plus the PGK-neo cassette gave rise to a 2.3
kb band (lane 4). Lanes 1±4 correspond to
the diagrams 1±4 in (A).
(C) Efficiency of Cre-recombinase-mediated
Notch1 deletion in various organs. Four 10-
week-old Notch1lox/loxMxCre1/2 mice were in-
jected four times i.p. at 2 day intervals with
300 mg of polyI-polyC. Genomic DNA from
various tissues was prepared 2 days after the
last injection and subjected to quantitative
Southern blot hybridization (PhosphorIm-
ager). The deletion efficacy was calculated
as the ratio of the signal from the inactivated
allele to the total signal of the wild-type plus
the inactivated allele and is expressed in
percent.
tive activation of Notch1 in immature thymocytes that (TCR) expression that was skewed toward a/b TCRs
(Robey et al., 1996; Washburn et al., 1997).resulted in a biased CD4 versus CD8 lineage decision
in favor of CD8 T cells as well as in a T cell receptor Inactivation of the mouse Notch1 gene did not cause
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gross developmental anomalies other than delayed and
disorganized somitogenesis that resulted in embryonic
lethality around day 10 of gestation (Swiatek et al., 1994;
Conlon et al., 1995).
To explore the consequences of an inactivation of
murine Notch1 beyond embryonic development, we made
use of an interferon-inducible Cre-recombinase trans-
gene (KuÈ hn et al., 1995) to inactivate an essential loxP-
flanked portion of the gene.
Results
Inducible Targeting of the Notch1 Gene
To introduce loxP sites into the Notch1 allele, ES cells
(129Sv/Ev; Reis et al., 1994) were electroporated with
a gene replacement vector containing a loxP-flanked
neomycin phosphotransferase gene driven by the phos-
phoglycerate kinase promoter (PGK-neo) that was in-
serted 2.7 kb upstream of the initiation start site and a
loxP site downstream of the exon encoding the signal
peptide of Notch1 (Figure 1A). G-418-resistant colonies
were screened by PCR and positive clones subjected
to Southern blot analysis (Figure 1B, lanes 1 and 2).
Targeted ES cell clones were transfected transiently
with an expression vector encoding Cre recombinase
under the control of the herpes simplex virus thymidine
kinase promoter and individual clones assayed for the
occurrence of two out of three possible recombination
events (Figure 1A): (1) loss of the PGK-neo cassette
alone, resulting in a Notch1 allele in which the exon
encoding the signal peptide was flanked by loxP sites;
(2) loss of the PGK-neo cassette plus the 3.5 kb gene
fragment, yielding a Notch1 allele in which the exon
Figure 2. Inactivation of Notch1 in Neonates Leads to Growth Retar-encoding the signal peptide was deleted. Single colo-
dation
nies were screened by PCR and positives verified by
(A) Comparison of the body size of five 4-week-old littermates
Southern blot analysis. Loss of the PGK-neo cassette treated with 5000±7000 U IFNa at days 3, 6, 9, and 11 after birth.
reverted the 3.7 kb EcoRI fragment, obtained through Left: two control littermates (Notch1lox/lox); right, three iNotch1lox/lox
homologous recombination, to the wt 5.8 kb fragment MxCre1/2 littermates. Mice were genotyped at the age of 21 days.
(B) Growth curve of one litter of six mice treated with IFNa as de-(Figure 1B, lane 3), whereas loss of the PGK-neo cas-
scribed in (A). n 5 3 for controls (Notch1lox/lox, open squares), andsette plus the 3.5 kb gene segment including the exon
n 5 3 for mutant mice (Notch1lox/loxMxCre1/2, open rectangles). Datafor the signal peptide resulted in a 2.3 kb fragment (Fig-
shown are means 6 SD.
ure 1B, lane 4). Two independent ES-cell clones from
each recombination event were used to generate chime-
ric founder males that were intercrossed with C57BL/6
Mice heterozygous for the loxP-flanked exon encod-females.
ing the signal peptide (Notch11/lox) were bred to Mx-CreAn alternative replacement vector was constructed in
transgenic mice harboring the Cre-recombinase trans-which the loxP-flanked PGK-neo cassette was placed
gene driven by the interferon-inducible Mx promoterimmediately upstream of the translation initiation start
(KuÈ hn et al., 1995) and offspring intercrossed to generatewithin the 59 UTR of the Notch1 gene (data not shown).
Notch1lox/loxMxCre1/2 mice (heterozygous for the Mx-CreMice derived from homologous insertion of this con-
transgene).struct were also normal, indicating that the insertion of
To assess the inducibility and efficacy of the Notch1a loxP palindrome within the 59 UTR of the Notch1 gene
inactivation, 3-month-old Notch1lox/loxMxCre1/2 mice re-had no significant effect on Notch1 expression. The re-
ceived four intraperitoneal (i.p.) injections of the inter-sults presented herein were generated using the tar-
feron inducer polyI-polyC at 2 day intervals. Two daysgeting strategy shown in Figure 1A. To ensure that the
after the last injection, genomic DNA from various tis-loss of the loxP-flanked exon would result in inactivation
sues was prepared and the gene deletion efficiencyof the Notch1 gene, mice heterozygous for the deletion
quantified by Southern blot analysis (Figure 1C). Theof the exon encoding the signal peptide (Notch11/2) were
deletion efficiency was highest in the liver, spleen, andintercrossed. From 101 offspring, no viable Notch12/2
bone marrow (85% to 100%), whereas in the lung, intes-mice were obtained. As reported (Swiatek et al., 1994;
tine, skin, kidney, or thymus the deletion efficiency var-Conlon et al., 1995), all Notch12/2 mice died in utero
around E9.5 of gestation (data not shown). ied from 35% to 65%.
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Figure 3. Abnormal Thymus Size and Mor-
phology in iNotch12/2 Mice
(A) Freshly isolated thymus from 4-week-
old Notch1lox/lox (control) versus Notch1lox/lox
MxCre1/2 mice. Littermates were injected
neonatally with IFNa as described in Figure
2A. Seventeen days after the last IFNa injec-
tion, iNotch12/2 mice showed a marked re-
duction in thymus size.
(B) At the age of 4 weeks, iNotch12/2 mice
showed a 5-fold reduction in thymocyte num-
bers. Numbers (3106) for control Notch1lox/lox
(1) versus Notch1lox/loxMxCre1/2 mice (2) are
shown as bar diagrams. Bars represent aver-
age values. Open triangles (control mice) and
open circles (iNotch12/2 mice) represent val-
ues from individual mice. n 5 8 for control;
n 5 11 for iNotch12/2 mice.
(C) Histological sections of the thymus of a
4-week-old iNotch12/2 and a control lit-
termate stained with hematoxylin and eosin
(magnification, 3100). M and C, medulla and
cortex.
Induced Inactivation of Notch1 in Newborn Mice At 4 weeks of age, iNotch12/2 mice had a markedly
smaller thymus (Figure 3A) with a 5-fold reduction inResulted in Growth Retardation and Abnormal
Thymic Development thymocyte numbers (Figure 3B) and an abnormal archi-
tecture where medullary and cortical regions could noNotch1lox/loxMxCre1/2 mice were intercrossed and new-
borns injected i.p. with IFNa at days 3, 6, 9, and 11 after longer be distinguished (Figure 3C).
birth without knowledge of their genotype. Genotyping
of Notch1lox/lox (control) versus Notch1lox/loxMxCre1/2 was Block in T Cell Development in iNotch12/2 Mice
To determine the stage at which the defect in thymicperformed 21 days after birth. IFNa-treated Notch1lox/lox
MxCre1/2 (hereafter iNotch12/2) mice showed reduced development occurred, cytofluorometric analysis of the
CD4, CD8, and T cell receptor (TCR) phenotype wasgrowth compared to IFNa-treated control Notch1lox/lox
littermates (Figure 2A). During the first 2 weeks after performed on thymocytes of Notch1lox/lox versus iNotch12/2
mice. Thymocytes from iNotch12/2 mice showed a mod-birth, iNotch12/2 mice showed a weight gain similar to
control littermates; however, they subsequently stabi- erate decrease in the percentages of mature single-
positive CD4182 (CD4 SP) and CD4281 (CD8 SP) cells,lized or decreased in weight, and some died for unknown
reasons. Body weight was measured, and a representa- a considerable decrease in CD4181 double-positive (DP)
cells and a relative increase in CD4282 double-negativetive growth curve from one litter consisting of three
control and three iNotch12/2 mice is shown in Figure 2B. (DN) T cells (Figure 4A). In absolute terms, CD4 SP were
reduced 5-fold, CD8 SP 4.4-fold, and DP thymocytesTo rule out any contribution of the Cre recombinase to
this phenotype, newborn wild-type or Mx-Cre transgenic 9-fold, whereas the DN population remained largely un-
affected. TCRg/d1 DN thymocytes and immature single-mice were neonatally injected with IFNa. Growth curves
were as for Notch1lox/lox controls (data not shown). positive thymocytes (ISP, defined by CD3lowCD42CD81)
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Figure 4. Reduction of T Cell Subsets in the
Thymus of iNotch12/2 Mice
(A) The thymus was isolated from 4-week-old
controls (Notch1lox/lox) or Notch1lox/loxMxCre1/2
mice that were treated neonatally with IFNa
as described in Figure 2A. The graph shows
a FACS analysis of CD4 versus CD8 cells as
well as histograms for TCR a/b expression
for total thymocytes. Percentages of CD4 SP,
CD41CD81 (DP), CD8 SP, and CD42CD82
(DN) cells are indicated in the quadrants.
(B) Absolute cell numbers (3106) for thymo-
cyte subsets described in (A) were calculated
and are shown as bar diagrams. The bars
represent average values. Open triangles
(control mice) and open circles (iNotch12/2
mice) represent values from individual mice.
n 5 8 for control; n 5 11 for iNotch12/2 mice.
were decreased 10-fold and 13-fold, respectively, as mice were further analyzed for the expression of CD24
(heat stable antigen, HSA), CD90 (Thy-1), CD117 (c-kit),compared to controls (Figure 4B). Thymic dentritic cells
were reduced to a similar extent as DP thymocytes (data and B220. CD24 is expressed on immature T cells and
B cells, CD90 is found on all thymic T cells, CD117 onnot shown).
To determine more precisely at what stage of thymo- immature T cells, and B220 on B cells. Based on the
expression of these markers, the most immature thymo-cyte development the block occurred in iNotch12/2 mice,
CD4282 TCR2 (CD32) triple-negative (TN) thymocytes cytes in normal mice are defined as being CD441
CD252CD241CD902/lowCD1171. Upon upregulation ofwere analyzed for the expression of CD44 and CD25,
which define distinct immature T cell populations (re- CD25, these cells give rise to a CD441CD251CD241
CD90lowCD1171 intermediate population that evolvesviewed in Godfrey and Zlotnik, 1993). iNotch12/2 mice
showed a block at or before the most immature T cell to a CD442CD251CD241CD901CD1172 phenotype and
eventually to the most mature TN population with down-stage, as most TN thymocytes were CD441CD252 (Fig-
ure 5A). While this population was increased 22-fold regulated CD25 (reviewed in Rodewald and Fehling,
1998). As shown in Figure 5C, over 90% of the CD441over the corresponding T cell population in control lit-
termates, the more mature populations of CD441CD251 cells in iNotch12/2 mice coexpressed CD24 as compared
to control littermates, where the majority of CD241 cellsand CD442CD251 cells were reduced 11-fold and 26-
fold, respectively (Figure 5B). CD442CD252 cells were were CD442. Only 2% of TN cells from iNotch12/2 mice
expressed CD90 as compared to 75% in the controls.virtually undetectable in iNotch12/2 mice (data not
shown). Within the CD441 TN population, no CD1171 cells were
detectable in iNotch12/2 mice, whereas controls had
50% CD1171 cells (data not shown).Accumulation of B Cells in the Thymus
of iNotch12/2 Mice Surprisingly, over 90% of this TN CD441CD252CD241
CD902CD1172 cell population that was increased 22-As expression of CD44 is not restricted to immature T
cell progenitors but is also expressed on B cells and fold in the thymus of iNotch12/2 mice (Figure 5B) were
B2201, compared to 10% in control mice (Figure 5C).activated mature T cells, TN thymocytes from iNotch12/2
Immunity
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Figure 5. iNotch12/2 Mice Show a Develop-
mental Arrest at the Stage of the Most Imma-
ture Thymocytes (CD441/CD252)
(A) Analysis of early thymocyte precursors in
mutant and control mice. Thymocytes gated
to eliminate cells expressing CD4, CD8, CD3e,
TCRa/b, and TCRg/d were stained for CD44
(Pgp-1) and CD25 (IL-2Ra). Percentages of
the different subsets are indicated in the
quadrants.
(B) Absolute cell numbers (3106) for the sub-
sets described in (A) were calculated and are
shown as bar diagrams. iNotch12/2 mice (2)
show an accumulation in absolute cell num-
bers of the most immature thymocytes com-
pared to control littermates (1). The bars
represent average values. Open triangles
(control mice) and open circles (iNotch12/2
mice) represent values from individual mice.
The statistic significance was calculated us-
ing the Student's T-test; p-values are indi-
cated above the bars. n 5 8 for control; n 5
8 for iNotch12/2 mice.
(C) Flow cytometric analysis of CD44, CD24,
CD90, and B220 expression in 4-week-old
Notch1lox/lox (controls) versus Notch1lox/lox
MxCre1/2 mice that were induced with IFNa
as described in Figure 2A. Representative
profiles of CD44 versus CD24, CD90, or B220
on thymocytes gated to eliminate cells ex-
pressing CD4, CD8, CD3e, TCR a/b, and TCR
g/d. Pecentages of the different T cell popula-
tions are indicated in the quadrants.
(D) Comparison of CD441/B2201 gated thy-
mocytes of control and iNotch12/2 mice
stained with monoclonal antibodies specific
for IgM, class II, CD5, and CD43. Controls,
solid line, filled histogram; iNotch12/2 mice,
dotted line.
Thus, altogether, B2201 cells were approximately 200- Evidence for a Cell Autonomous T Cell
Differentiation Anomalyfold increased in the thymus of iNotch12/2 mice as com-
pared to controls. Thymic B2201 cells from iNotch12/2 in iNotch12/2 Mice
To assess whether the abnormal thymic colonizationmice were further analyzed with regard to B cell±specific
markers including IgM, major histocompatibility class II observed in iNotch12/2 mice was due to the loss of Notch1
on thymocyte precursors or on thymic stromal cells,antigens (class II), CD5, and CD43, and compared to
the small thymic B2201 population found in littermate bone marrow from IFNa-treated control Notch1lox/lox or
iNotch12/2 mice was transferred into lethally irradiatedcontrols. In wild-type mice, thymic B cells represent
around 0.2% of total thymic cells (Inaba et al., 1990). As wild-type hosts. The Notch1 gene was inactivated close
to 100% in bone marrow cells from iNotch12/2 mice, asshown in Figure 5D, IgM expression in thymic B2201
cells of iNotch12/2 mice was biphasic as approximately revealed by Southern blot analysis (Figure 6A, lanes 3
and 4 versus lanes 1 and 2). Chimeras were analyzed 6half of the cells were IgM2/low and half IgM1. Furthermore,
B2201 cells from iNotch12/2 mice were class IIbright, months after transplantation. As shown in Figure 6B,
thymic colonization was reminiscent of the thymic pheno-CD5low, and CD432, as compared to the known class II
intermediate, CD51, and CD431 phenotype in the con- type observed in newborn iNotch12/2 mice (Figure 4B).
While mature CD4 SP and CD8 SP were reduced 3-foldtrols (Miyama-Inaba et al., 1988). Thus, B cells found in
thymus of iNotch12/2 mice differed in all four markers and DP thymocytes were reduced 4-fold, the DN thymo-
cyte population was largely unaffected. TCRg/d1 DNfrom normally occurring thymic B cells but resembled
immature B cells normally found in the bone marrow thymocytes as well as ISP cells were reduced 11-fold
and 7-fold, respectively. The TN population revealed a(data not shown). Cytofluorometric staining patterns re-
vealed no differences between bone marrow and periph- developmental arrest at or before the stage of the earli-
est immature population (CD441CD252) (Figure 6C).eral lymph node B cells from iNotch12/2 versus control
littermates (data not shown). Again, the majority of CD44-positive cells expressed
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Figure 6. The Defect in T Cell Differentiation of iNotch12/2 Precursors Is Cell Autonomous
Two groups of six 12-week-old control mice (Notch1lox/lox) and Notch1lox/loxMxCre1/2 received four i.p. injections of polyI-polyC (300 mg) at 2
day intervals. The bone marrow of these mice was used to reconstitute the immune system of lethally irradiated C57/Bl6 mice.
(A) Southern blot analysis of genomic DNA from pooled donor bone marrow from control (lanes 1 and 2, pool of three mice per lane) and
iNotch12/2 mice (lanes 3 and 4, pool of three mice per lane). Genomic DNA was prepared 2 days after the last polyI-polyC injection. Notch1
mutant bone marrow showed close to a 100% recombination efficiency.
(B) The thymus of chimeric mice was analyzed 6 months after bone marrow transplantation. Cells were counted and stained with the indicated
specific antibodies. Absolute cell numbers (3106) were calculated and are shown as bar diagrams. The bars represent average values. Open
triangles (control donor bone marrow) and open circles (iNotch12/2 donor bone marrow) represent values from individual mice. The statistical
significance was calculated using Student's T-test; p-values are indicated. n 5 11 for chimeras transplanted with control bone marrow (1);
n 5 8 for chimeras transplanted with iNotch12/2 bone marrow (2).
(C) Phenotype of DN thymocytes in chimeric mice transplanted with control or iNotch12/2 bone marrow. Thymocytes were gated and stained
as in Figure 5A.
(D) Southern blot analysis of genomic DNA from bone marrow (B), spleen (S), and thymus (T) of chimeras reconstituted with control or
iNotch12/2 bone marrow. Conditions and probe see Figures 1A and 1B.
(E) Southern blot analysis of genomic DNA from the thymus of three individual chimeras reconstituted with iNotch12/2 bone marrow. Conditions
and probe see Figures 1A and 1B.
B220, were biphasic for IgM expression, and were class control or iNotch12/2 mice mixed in a 1:1 ratio with bone
marrow from wild-type mice. The allelic markers CD45.2II positive (data not shown), similar to the patterns ob-
served in 4-week-old iNotch12/2 mice (Figures 5C and and CD45.1, respectively, were used to distinguish the
donor populations. Analysis of such mixed bone marrow5D). When bone marrow from control Notch1lox/lox mice
was transplanted into lethally irradiated wild-type hosts, chimeras 6 months after reconstitution revealed a com-
plete absence in the thymus as well as in the peripheryT cell development was unaffected (data not shown).
Even though thymic T cell development was affected of any iNotch12/2 donor bone marrow±derived T cells
(Figure 7). The distribution of the two allelic markers insimilarly in neonatally induced iNotch12/2 mice and adult
bone marrow chimeras grafted with iNotch12/2 bone lymph node cells pointed to an equivalent contribution of
the different donor populations (Figure 7A, upper panel).marrow, the latter displayed only a moderate reduction
in mature SP thymocytes. Southern blot analysis of the While B2201 cells were equally represented in wild-type
and iNotch12/2 mice derived populations and while anNotch1 deletion in the bone marrow, spleen, and thymus
of reconstituted chimeras indicated that the bone mar- expected proportion of CD31 cells was detected in the
controls, CD31 cells derived from iNotch12/2 (CD45.2row was still entirely derived from Notch1-deleted cells
(Figure 6D). Interestingly, however, the thymus seemed tagged) precursors were undetectable (Figure 7A, lower
panels). Similar results were obtained upon analysis ofto have undergone a variable degree of repopulation
from wild-type cells (10%-75%) during the 6 month re- splenocytes and peripheral blood lymphocytes (data not
shown). The thymus of mice repopulated with mixedcovery period, as evidenced by the detection of a Notch1
wild-type restriction pattern (Figures 6D and 6E). To wild-type (CD45.1 tagged) and iNotch12/2 (CD45.2
tagged) bone marrow was virtually devoid of CD45.21explore whether T cell maturation from residual wild-
type precursors present in the iNotch12/2 donor cell pop- cells (Figure 7B, upper panel) and the few residual cells
proved to be B cells (Figure 7B, lower panels).ulation may have been favored, lethally irradiated hosts
were reconstituted with bone marrow from Notch1lox/lox It is noteworthy that based on the staining of the
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Figure 7. Competitive Repopulation of Le-
thally Irradiated C57/Bl6 Mice Reveals a
Complete Inability of iNotch12/2 Bone Marrow
to Generate T Cells
Two groups of five chimeric mice were ana-
lyzed 6 months after reconstitution with a 1:1
mixture of wild-type (CD45.11) and control
(Notch1lox/lox, CD45.21) or iNotch12/2 (CD45.21)
bone marrow. Data are from representative
chimeras in each group.
(A) FACS profile of lymph node cells stained
with anti-CD45.1, anti-CD45.2, anti-B220,
and anti-CD3 antibodies. The upper panel
shows the relative contribution of the com-
peting CD45.1 versus CD45.2 donor bone
marrow±derived populations. The lower panel
shows the distribution of CD31 versus B2201
cells within the CD45.11 or the CD45.21 pop-
ulations.
(B) FACS profile of thymocytes stained with
anti-CD45.1, anti-CD45.2, anti-CD4, anti-CD8,
and anti-B220 antibodies. The upper panel
shows the relative contribution of the com-
peting CD45.1 versus CD45.2 donor bone mar-
row±derived populations. The middle panel
shows the distribution of CD41 versus CD81
cells within the CD45.11 or the CD45.21 pop-
ulations, and the lower panel shows distribu-
tion of B2201 cells within the CD42CD82 (DN)
CD45.21 population.
surface antigens Mac-1, GR1, Ter119, and NK1.1, both these mice started to regain weight after an approxi-
mately 2 week stagnation period. However, even aftermyeloid and erythroid lineages as well as NK cells de-
6 months, iNotch12/2 mice failed to reach the weight ofrived from iNotch12/2 (CD45.2 tagged) bone marrow
their littermate controls. A similar phenotype was re-were normally represented (unpublished data).
ported recently for mice that lack gelatinase B and
showed a transient growth retardation due to abnormalDiscussion
skeletal growth plate vascularization and ossification
(Vu et al., 1998). Interestingly, the gelatinase B promoterWe report the initial phenotypic analysis of mice in which
contains multiple putative binding sites for RBP-Jk thatan essential portion of the Notch1 gene was flanked by
can associate with activated Notch1 to form a transcrip-loxP sites (Figure 1A) and deleted inducibly through the
tional activator of Notch target genes (Jarriault et al.,activation of an interferon-responsive Cre recombinase
1995). The possibility that gelatinase B is under the con-transgene. To verify that the loxP-flanked portion of the
trol of Notch1 and might be functionally affected inNotch1 gene was essential for its function, mice were
iNotch12/2 mice is currently being explored.generated from ES cell clones in which this portion was
Young iNotch12/2 mice showed a severe anomaly indeleted upon transient expression of Cre recombinase.
thymocyte development. Loss of Notch1 during postna-These Notch12/2 mice died around E9.5 with a pheno-
tal development led to a decrease of mature thymocytestype described in earlier reports on constitutively inacti-
of both a/b and g/d lineages, as well as developmentally
vated mouse Notch1 (Swiatek et al., 1994; Conlon et al.,
intermediate (DP, ISP) and immature TN (CD42CD82
1995). I.p. administration of either IFNa or polyI-polyC CD32) thymocyte subsets (Figure 4), suggesting a devel-
to Notch1lox/loxMxCre1/2 mice resulted in variable deletion opmental arrest at or before the most immature thymo-
of Notch1 in different organs (Figure 1C). Consistent cyte precursor stage (CD441/CD252) (Figure 5).
with previous observations (KuÈ hn et al., 1995), the dele- A recently described lymphoid precursor population
tion was most efficient in the liver, spleen, and bone lacking myeloid differentiation potential has been de-
marrow. fined as Lin2IL-7R1Thy12Sca1loCD117lo (Kondo et al.,
To investigate the putative role of Notch1 in postnatal 1997) and might be responsible for thymic colonization
development, Notch1lox/loxMxCre1/2 mice were crossed from the bone marrow. During thymus development, T
with Notch1lox/lox mice and litters treated with IFNa. lineage precursors differentiate along a complex devel-
Notch1lox/loxMxCre1/2 offspring (iNotch12/2) but not IFNa- opmental pathway and undergo a series of phenotypic
treated controls (Notch1lox/lox) displayed a severe growth changes that can be monitored by the differential ex-
retardation (Figure 2). Although administration of high pression of CD44 and CD25 (Godfrey and Zlotnik, 1993).
doses of IFNa to suckling mice was reported to be The earliest precursor subset, expressing CD44 and
growth inhibitory and toxic (Gresser et al., 1975, 1981), CD117 but not CD25, has been shown to still have mul-
the IFNa doses used to induce the gene deletion clearly tipotential activity as it can give rise to T, B, NK,
had no detectable effect on controls. The observed and dendritic cells (reviewed in Shortman and Wu,
1996). Subsequent subsets are defined as CD441CD251growth retardation in iNotch12/2 mice was transient as
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CD1171, CD442CD251CD1172, and CD442CD252CD1172 mature in a Notch1-independent manner or escape be-
cause of redundant Notch signaling but were likely de-(reviewed in Godfrey and Zlotnik, 1993). Concurrent to
these phenotypic changes, somatic recombination and rived from cells that had already reached more mature
stages at the time when Notch1 was inactivated. T celltranscriptional regulation of TCR genes, as well as prolif-
eration of selected subsets, occurs (reviewed in Fehling lineages in chimeras reconstituted with marrow iNotch12/2
(Figure 6) were likely derived from rare precursors thatand von Boehmer, 1997; Kang and Raulet, 1997; Rode-
wald and Fehling, 1998). escaped Notch1 inactivation.
Notch1 protein is expressed at high levels in immatureThe presumed precursor population that accumulated
in the thymus of iNotch12/2 mice resembled the earli- outer cortical CD42CD82CD241 thymocytes (Hasserjian
et al., 1996), and several observations point to theest thymocyte precursor population (CD441CD252TN).
However, these cells did not express thymocyte precur- involvement of Notch1-mediated signaling at different
stages of T cell maturation, such as those leading tosor markers such as CD117 and CD90 but instead ex-
pressed typical B cell markers such as B220, CD19, IgM, CD8 versus CD4 (Robey et al., 1996) and TCR g/d versus
TCR a/b lineage choices (Washburn et al., 1997).and MHC class II. Normally, thymic B cells represent
only a small subset (0.2%) of thymic cells (Inaba et al., Recently, an activated form of Notch1 was found to
exhibit antiapoptotic properties that may be relevant1990). These thymic B cells that are found in the thymic
medulla and have a specific phenotype (B2201IgMlo for CD41CD81 DP thymocyte maturation (Deftos et al.,
1998). Interestingly, an activated form of Notch1 intro-classIIintCD51CD431) (Miyama-Inaba et al., 1988) that
distinguishes them from peripheral B cells may play a duced through a retrovirus into a stem cell containing
population that was used for bone marrow reconstitu-role in negative T cell selection (Ferrero et al., 1999).
The B cell population found in the thymus of iNotch12/2 tion gave rise to clonal leukemias of exclusively imma-
ture T cell phenotypes (Pear et al., 1996). The data pre-mice differed in four out of five of these phenotypic
markers (Figure 5D) and resembled B cells normally sented here suggest that Notch1 plays an essential role
at an early developmental branch point when the T cellfound in the bone marrow.
Intercellular interactions between precursor cells and lineage is induced. It remains unclear in which compart-
ment the absence of Notch1 affects this cell fate deci-the thymic stroma are essential for normal thymocyte
development and maturation to occur (reviewed in An- sion. Notch12/2-deficient lymphoid precursors (Kondo
et al., 1997) could fail to respond to instructive signalsderson et al., 1996). To clarify whether the aborted T
cell development and the appearance of atypical B cells within the stromal microenvironment of the bone marrow
and/or fail to home to the thymus. Alternatively, theseobserved in the thymus of iNotch12/2 mice was due to
a dysfunctional thymic microenvironment or to a cell precursors may reach the thymus but fail to activate the
Notch1 pathway in response to the thymic microenviron-autonomous defect at the level of immature precursors,
bone marrow chimeras were generated using iNotch12/2 ment and remain (inefficiently) directed toward a B cell
fate. With the exception of their abnormal presence indonor cells. These experiments largely recapitulated the
observations made in young iNotch12/2 mice (Figure 6), the thymus, B cells seemed to develop normally in the
absence of Notch1 signaling, since normal mature B cellsuggesting that the developmental T cell arrest was
indeed cell autonomous. The arrest proved incomplete, phenotypes were observed in competitively repopulated
lymph nodes (Figure 7A) as well as in the spleen andhowever, and a significant degree of T cell maturation
was observed. Even though the gene deletion in the within peripheral blood lymphocytes (data not shown).
Likewise, myeloid and erythroid lineages were generatedbone marrow of iNotch12/2 mice seemed complete (Fig-
ure 6D), it could not be ruled out that some precursor in similar proportions from both wild-type and iNotch12/2-
deficient bone marrow, suggesting that Notch1 is dis-cells had escaped. Interestingly, Southern blot analysis
of genomic DNA derived from bone marrow, spleen, or pensable for hematopoiesis.
The molecular consequences of Notch1 inactivation inthymocytes 6 months after bone marrow transplantation
revealed that the reconstituted bone marrow was en- lymphoid precursors remain elusive. Both an instructive
role for Notch1 in T cell fate induction or a permissivetirely derived from iNotch12/2 cells, whereas the chimeric
thymus contained an individually variable and occasion- role for the outgrowth of T cell precursors are compatible
with the phenotype reported here. The inducible inacti-ally abundant wild-type population (Figures 6D and 6E).
vation model presented here should provide a novelAfter this period, radio-resistant host thymocytes have
basis for exploring the essential functions and molecularlargely disappeared and were therefore ruled out as a
events of Notch1 signaling.source for the wild-type signal (Kadish and Basch, 1975;
Ceredig and MacDonald, 1982). To assess whether resid-
Experimental Proceduresual wild-type thymocytes had expanded and matured
to partially compensate for the iNotch12/2-mediated de-
Generation of Mice with a loxP-Flanked Notch1 Allele
velopmental arrest, lethally irradiated hosts were repop- A genomic l GEM-11 library (MuÈ ller et al., 1994) was screened using
ulated with mixed wild-type and iNotch12/2 bone marrow two pairs of overlapping oligonucleotides, muNotch1pr1u GTGGTG
that was tagged with allelic markers (Figure 7). The anal- TGCGTCAACGTCCGATCCCCGCCGGCCACCCC, muNotch1pr1l
CGGCGGCCTCTTGGGGTGGCCGGCGGGGATCGGACGTT andysis of such mixed chimeras 6 months after their recon-
muNotch1pr2u TGCTCCCAGCCAAGTGGGACCTGCCTGAATGGAstitution unequivocally revealed a virtually complete ab-
GGTAGG, muNotch1pr2l GGCCACTTCGCACCTACCTCCATTCAGGsence of any iNotch12/2-derived T cell lineages, both in
CAGGTCCCACT. A 12 kb genomic Notch1 clone encompassing the
the thymus and in the periphery. Thus, thymic T cell exons coding for the leader peptide and the first EGF repeat was
lineages beyond the CD441/CD252 stage observed in used to generate a 1.3 kb BamHI fragment containing the putative
Notch1 promoter region, a 3.5 kb BamHI±XhoI fragment containingyoung iNotch12/2 mice (Figure 4) presumably did not
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the exon coding for the leader peptide, and a 4.5 kb XhoI±SacII Histological Analysis
The thymus from IFNa-treated control (Notch1lox/lox) or Notch1lox/loxfragment including the exon encoding the first EGF repeat (Figure
1A). These fragments were cloned into the NotI, ASCI, and PmeI MxCre1/2 mice was fixed in 4% paraformaldehyde for 4 hr and
embedded in paraffin. Sections (4 mm) were stained with hematoxy-sites, respectively, of the TNLOX1-3 targeting vector. All loxP sites
of the targeting vector were sequenced and the orientation of the lin-eosin.
inserts verified by restriction mapping and sequencing. Twenty mi-
crograms of the targeting vector were linearized by SalI digestion Flow Cytometry
and electroporated into the GS-1 embryonic stem cell line (Reis et Single cell suspensions of lymphocytes from thymus, spleen, lymph
al., 1994). Cells were subjected to G-418 selection (400 mg/ml), and node, or bone marrow were prepared and stained for three- or four-
single colonies were analyzed for homologous recombination of the color FACS analysis by standard procedures. Results were analyzed
targeting vector by PCR using Notch135JTGAGGCCTTTTCTTTTT using either LYSYS II or CellQuest software on FACScan or FACS
GGAG and Neo-35KCGCCTTCTTGACGAGTTCTTC as primers. PCR Calibur flow cytometers (Becton Dickinson), respectively. Most of
positive colonies were verified by Southern blot analysis using a the fluorescein, Cy-5, and biotin conjugates were prepared in one
750 bp BamHI±EcoRI fragment as a probe, derived from the 59 of our laboratories. These included anti-CD4 (GK 1.5), anti-CD8
upstream region of the Notch1 locus (Figure 1A). The frequency of (53.6.7), anti-CD25 (PC61.5), anti-CD44 (I. M.781), and anti-IgM (MB
homologous recombination events was 1:120. The complete inte- 86; Nishikawa et al., 1986). Anti-CD24 (M1/69), anti-CD3e-FITC,
gration of the 39 region including the downstream loxP3 site was anti-TCRb-FITC and -PE, anti-TCRg/d-FITC, anti-B220-APC or
verified by PCR using loxP3-62WGGGTAGATAGGAGTAAGGGA -CyChrome, anti-CD44-CyChrome, anti-CD4-CyChrome, anti-CD8-
CCA and loxP3-62V GTGTAGGGCTGAGCTCGAAAACC. APC, anti-CD43-FITC, anti-CD19-biotin, anti-class II-PE, anti-CD24-
Three independent ES cell clones were transiently transfected PE, and anti-CD5-PE conjugates were from PharMingen. PE-Strep-
with an expression vector encoding Cre-recombinase (pMC-Cre) tavidin, CD25-PE, CD44-PE, B220-PE, and CD90-PE were from
generously provided by Werner MuÈ ller and Klaus Rajewsky, Co- Caltag Laboratories. To analyze DN CD32 thymocytes, staining was
logne. One hundred colonies per ES-cell clone were screened by performed using a pool of FITC direct conjugates (CD4, CD8, CD3,
PCR and Southern blot analysis either for the loss of the PGK-neo TCRa/b, and TCRg/d). Dead cells and debris were removed by ap-
cassette alone or the loss of the PGK-neo cassette plus the 3.5 kb propriate gating of FSC and SSC.
gene segment. Primers used: PCR2 Cre loxP1-59T GATCGGCCGCC
TCGAGATAAC and PCR2 Cre loxP1-59S GCCTACCTGCCATCCCG Bone Marrow Chimeras
TCTG. Genomic DNA isolated from PCR positive colonies was di- Bone marrow chimeras were generated using T cell±depleted
gested with EcoRI and analyzed by Southern blotting using the 750 bone marrow cells from IFNa-treated control (Notch1lox/lox) or
bp BamHI±EcoRI fragment as a probe (Figure 1A). ES cell clones in Notch1lox/loxMxCre1/2 mice. Ten-week-old hosts (C57BL/6L) were
which the exon encoding the leader peptide was flanked by loxP given 1000 rads of g-irradiation 24 hr prior to receiving 5±10 3
sites or in which this exon was deleted were used to generate 106 donor bone marrow cells intravenously. Mixed chimeras were
chimeric founder mice by microinjection into C57BL/6J blastocysts. generated using a 1:1 mixture of T cell±depleted bone marrow cells
Heterozygous Notch1lox/lox mice were bred to Mx-1-Cre mice (KuÈ hn from CD45.11 wild-type and CD45.21 Notch1lox/lox or iNotch12/2 mice.
et al., 1995) to generate Notch11/loxMxCre1/2 mice that were inter- Radiation chimeras were maintained on antibiotic water and ana-
crossed to generate Notch1lox/loxMxCre1/2 mice. Mice were geno- lyzed after 6 months.
typed for homozygosity of the loxP sites and the presence of the
Mx-1-Cre transgene by PCR. Primers used: 59 of loxP1 tv2 CTGACTT Acknowledgments
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TGT; generating a 350 bp fragment in the presence of a loxP site We thank Rose Lees for help with generating bone marrow chimeras,
and a 300 bp fragment for the wt allele; Cre1 GGCCCCATGGCATCC Isabel Ferrero for dendritic cell analysis, Jeannine Bamat for histo-
AATTTACTGACCGTACAC, Cre2 TCGCTCGAGGTGATCGCCATCTT logical work, and Werner Held for stimulating discussions. This work
CCAGCAG, generating a 1 kb fragment. was supported in part by the Swiss National Science Foundation,
the Veillon Foundation, and the Leenaards Foundation (G. S.).
Production of Murine IFN-a11
Received April 8, 1999.The cDNA encoding murine IFN-a11 was obtained by PCR from the
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